STAT+: Biotech startups are hungry for dollars. Here’s what one pharma executive was looking for at JPM
The balance of power between biotech startups and big pharma has shifted — but Bayer executive Marianne De Backer is still looking for deals.
News
STAT+: FDA’s Califf says congressional report on Aduhelm controversy contained “no surprises”
FDA head Robert Califf made his first public comments following a congressional investigation into the agency’s role in approving Aduhelm. […]
News
STAT+: Regeneron’s George Yancopoulos admits some regret, but ‘I don’t apologize’
In some of his first public remarks since getting booed on stage last month over Alzheimer’s drug remarks, Regeneron’s George Yancopoulos acknowledged in an interview he could’ve handled things differently. […]
News
STAT+: After blazing trails in RNA-targeted drugs, Ionis jumps into gene editing
Ionis Pharmaceuticals — which blazed a trail in RNA-targeted medicines — is jumping into gene editing with a new partnership with Metagenomi. […]
